Event Title

Touro College & University System Distinguished Research Speaker: Fructose: A Sweet Way to Make 'Foie Gras' and Increase

Type

Speech

Location

New York, NY

Start Date

1-5-2018 2:00 PM

End Date

1-5-2018 2:30 PM

Description

“Fructose: a sweet way to make “foie gras” and increase your risk for diabetes and cardiovascular disease” -- There is increasing evidence from both epidemiologic and interventional studies of the deleterious effects of consuming sugar-sweetened beverages and other foods containing fructose and other added sugars. However, the causal effect of sugar has been questioned because most sugar studies have a concomitant excess calorie intake. Recent sugar studies have shown that sugar-sweetened beverages in energy balance also lead to the same deleterious effects. Chronically elevated de novo lipogenesis (DNL) during both fasting and feeding may be a key mechanism in the link between consumption of added sugar and metabolic abnormalities, including obesity, high lipid levels, cardiovascular disease, NAFLD, insulin resistance, and type 2 diabetes.

This document is currently not available here.

Share

COinS
 
May 1st, 2:00 PM May 1st, 2:30 PM

Touro College & University System Distinguished Research Speaker: Fructose: A Sweet Way to Make 'Foie Gras' and Increase

New York, NY

“Fructose: a sweet way to make “foie gras” and increase your risk for diabetes and cardiovascular disease” -- There is increasing evidence from both epidemiologic and interventional studies of the deleterious effects of consuming sugar-sweetened beverages and other foods containing fructose and other added sugars. However, the causal effect of sugar has been questioned because most sugar studies have a concomitant excess calorie intake. Recent sugar studies have shown that sugar-sweetened beverages in energy balance also lead to the same deleterious effects. Chronically elevated de novo lipogenesis (DNL) during both fasting and feeding may be a key mechanism in the link between consumption of added sugar and metabolic abnormalities, including obesity, high lipid levels, cardiovascular disease, NAFLD, insulin resistance, and type 2 diabetes.